nodes	percent_of_prediction	percent_of_DWPC	metapath
Sparfloxacin—SLC22A5—Niacin—atherosclerosis	0.179	0.233	CbGbCtD
Sparfloxacin—ABCC2—Ezetimibe—atherosclerosis	0.119	0.154	CbGbCtD
Sparfloxacin—ABCC2—Simvastatin—atherosclerosis	0.11	0.143	CbGbCtD
Sparfloxacin—ABCC2—Pravastatin—atherosclerosis	0.108	0.14	CbGbCtD
Sparfloxacin—ABCC2—Lovastatin—atherosclerosis	0.108	0.14	CbGbCtD
Sparfloxacin—ABCB1—Ezetimibe—atherosclerosis	0.0386	0.0503	CbGbCtD
Sparfloxacin—ABCB1—Simvastatin—atherosclerosis	0.0359	0.0468	CbGbCtD
Sparfloxacin—ABCB1—Pravastatin—atherosclerosis	0.0352	0.0458	CbGbCtD
Sparfloxacin—ABCB1—Lovastatin—atherosclerosis	0.0352	0.0458	CbGbCtD
Sparfloxacin—ABCC2—Irinotecan Pathway—NPC1—atherosclerosis	0.00382	0.169	CbGpPWpGaD
Sparfloxacin—TOP2A—Fluvastatin—Rosuvastatin—atherosclerosis	0.00161	0.343	CbGdCrCtD
Sparfloxacin—TOP2A—Simvastatin—Pravastatin—atherosclerosis	0.00154	0.328	CbGdCrCtD
Sparfloxacin—TOP2A—Simvastatin—Lovastatin—atherosclerosis	0.00154	0.328	CbGdCrCtD
Sparfloxacin—ABCC2—Drug Induction of Bile Acid Pathway—CYP7A1—atherosclerosis	0.00123	0.0544	CbGpPWpGaD
Sparfloxacin—ABCC2—ABC-family proteins mediated transport—ABCG4—atherosclerosis	0.000983	0.0435	CbGpPWpGaD
Sparfloxacin—ABCC2—ABC-family proteins mediated transport—ABCG8—atherosclerosis	0.000942	0.0417	CbGpPWpGaD
Sparfloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—atherosclerosis	0.00078	0.0345	CbGpPWpGaD
Sparfloxacin—ABCC2—ABC-family proteins mediated transport—ABCG1—atherosclerosis	0.000745	0.033	CbGpPWpGaD
Sparfloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP7A1—atherosclerosis	0.000707	0.0313	CbGpPWpGaD
Sparfloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—atherosclerosis	0.000612	0.0271	CbGpPWpGaD
Sparfloxacin—ABCC2—ABC-family proteins mediated transport—ABCG5—atherosclerosis	0.000585	0.0259	CbGpPWpGaD
Sparfloxacin—ABCB1—Drug Induction of Bile Acid Pathway—CYP7A1—atherosclerosis	0.000579	0.0256	CbGpPWpGaD
Sparfloxacin—Urinary tract infection—Pravastatin—atherosclerosis	0.00048	0.00235	CcSEcCtD
Sparfloxacin—Chills—Lovastatin—atherosclerosis	0.000471	0.0023	CcSEcCtD
Sparfloxacin—Cough—Rosuvastatin—atherosclerosis	0.00047	0.0023	CcSEcCtD
Sparfloxacin—Erythema multiforme—Simvastatin—atherosclerosis	0.000464	0.00227	CcSEcCtD
Sparfloxacin—Sinusitis—Pravastatin—atherosclerosis	0.000464	0.00227	CcSEcCtD
Sparfloxacin—Alopecia—Lovastatin—atherosclerosis	0.000463	0.00227	CcSEcCtD
Sparfloxacin—ABCB1—ABC-family proteins mediated transport—ABCG4—atherosclerosis	0.000462	0.0204	CbGpPWpGaD
Sparfloxacin—Arthralgia—Rosuvastatin—atherosclerosis	0.000459	0.00224	CcSEcCtD
Sparfloxacin—Myalgia—Rosuvastatin—atherosclerosis	0.000459	0.00224	CcSEcCtD
Sparfloxacin—Alopecia—Ezetimibe—atherosclerosis	0.000455	0.00222	CcSEcCtD
Sparfloxacin—Haemoglobin—Niacin—atherosclerosis	0.000453	0.00222	CcSEcCtD
Sparfloxacin—Rhinitis—Niacin—atherosclerosis	0.000452	0.00221	CcSEcCtD
Sparfloxacin—Hepatitis—Niacin—atherosclerosis	0.00045	0.0022	CcSEcCtD
Sparfloxacin—Haemorrhage—Niacin—atherosclerosis	0.00045	0.0022	CcSEcCtD
Sparfloxacin—Flatulence—Lovastatin—atherosclerosis	0.00045	0.0022	CcSEcCtD
Sparfloxacin—Hypoaesthesia—Niacin—atherosclerosis	0.000448	0.00219	CcSEcCtD
Sparfloxacin—Dysgeusia—Lovastatin—atherosclerosis	0.000447	0.00219	CcSEcCtD
Sparfloxacin—Rhinitis—Pravastatin—atherosclerosis	0.000445	0.00218	CcSEcCtD
Sparfloxacin—Oedema peripheral—Niacin—atherosclerosis	0.000444	0.00217	CcSEcCtD
Sparfloxacin—Hepatitis—Pravastatin—atherosclerosis	0.000444	0.00217	CcSEcCtD
Sparfloxacin—Confusional state—Rosuvastatin—atherosclerosis	0.000443	0.00217	CcSEcCtD
Sparfloxacin—ABCB1—ABC-family proteins mediated transport—ABCG8—atherosclerosis	0.000443	0.0196	CbGpPWpGaD
Sparfloxacin—Back pain—Lovastatin—atherosclerosis	0.000442	0.00216	CcSEcCtD
Sparfloxacin—Hypoaesthesia—Pravastatin—atherosclerosis	0.000441	0.00216	CcSEcCtD
Sparfloxacin—Flatulence—Ezetimibe—atherosclerosis	0.000441	0.00216	CcSEcCtD
Sparfloxacin—Pharyngitis—Pravastatin—atherosclerosis	0.00044	0.00215	CcSEcCtD
Sparfloxacin—Chills—Simvastatin—atherosclerosis	0.00044	0.00215	CcSEcCtD
Sparfloxacin—Alopecia—Simvastatin—atherosclerosis	0.000434	0.00212	CcSEcCtD
Sparfloxacin—Back pain—Ezetimibe—atherosclerosis	0.000433	0.00212	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000431	0.00211	CcSEcCtD
Sparfloxacin—Tremor—Lovastatin—atherosclerosis	0.000428	0.00209	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Lovastatin—atherosclerosis	0.000424	0.00207	CcSEcCtD
Sparfloxacin—Flatulence—Simvastatin—atherosclerosis	0.000421	0.00206	CcSEcCtD
Sparfloxacin—Tinnitus—Niacin—atherosclerosis	0.00042	0.00206	CcSEcCtD
Sparfloxacin—Erythema multiforme—Pravastatin—atherosclerosis	0.000419	0.00205	CcSEcCtD
Sparfloxacin—Dysgeusia—Simvastatin—atherosclerosis	0.000418	0.00205	CcSEcCtD
Sparfloxacin—Angioedema—Lovastatin—atherosclerosis	0.000417	0.00204	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000416	0.00203	CcSEcCtD
Sparfloxacin—Tinnitus—Pravastatin—atherosclerosis	0.000414	0.00202	CcSEcCtD
Sparfloxacin—Malaise—Lovastatin—atherosclerosis	0.000412	0.00201	CcSEcCtD
Sparfloxacin—Vertigo—Lovastatin—atherosclerosis	0.00041	0.00201	CcSEcCtD
Sparfloxacin—Angioedema—Ezetimibe—atherosclerosis	0.000409	0.002	CcSEcCtD
Sparfloxacin—Chills—Niacin—atherosclerosis	0.000404	0.00198	CcSEcCtD
Sparfloxacin—Malaise—Ezetimibe—atherosclerosis	0.000404	0.00198	CcSEcCtD
Sparfloxacin—Arrhythmia—Niacin—atherosclerosis	0.000402	0.00197	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000401	0.00196	CcSEcCtD
Sparfloxacin—Tremor—Simvastatin—atherosclerosis	0.0004	0.00196	CcSEcCtD
Sparfloxacin—Alopecia—Niacin—atherosclerosis	0.000398	0.00195	CcSEcCtD
Sparfloxacin—Chills—Pravastatin—atherosclerosis	0.000398	0.00195	CcSEcCtD
Sparfloxacin—Insomnia—Rosuvastatin—atherosclerosis	0.000398	0.00195	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Simvastatin—atherosclerosis	0.000396	0.00194	CcSEcCtD
Sparfloxacin—Arrhythmia—Pravastatin—atherosclerosis	0.000396	0.00194	CcSEcCtD
Sparfloxacin—Palpitations—Ezetimibe—atherosclerosis	0.000396	0.00194	CcSEcCtD
Sparfloxacin—Paraesthesia—Rosuvastatin—atherosclerosis	0.000395	0.00193	CcSEcCtD
Sparfloxacin—Alopecia—Pravastatin—atherosclerosis	0.000392	0.00192	CcSEcCtD
Sparfloxacin—Cough—Ezetimibe—atherosclerosis	0.000391	0.00191	CcSEcCtD
Sparfloxacin—Angioedema—Simvastatin—atherosclerosis	0.00039	0.00191	CcSEcCtD
Sparfloxacin—Arthralgia—Lovastatin—atherosclerosis	0.000389	0.0019	CcSEcCtD
Sparfloxacin—Chest pain—Lovastatin—atherosclerosis	0.000389	0.0019	CcSEcCtD
Sparfloxacin—Myalgia—Lovastatin—atherosclerosis	0.000389	0.0019	CcSEcCtD
Sparfloxacin—Anxiety—Lovastatin—atherosclerosis	0.000387	0.0019	CcSEcCtD
Sparfloxacin—Dyspepsia—Rosuvastatin—atherosclerosis	0.000387	0.00189	CcSEcCtD
Sparfloxacin—Hypertension—Ezetimibe—atherosclerosis	0.000387	0.00189	CcSEcCtD
Sparfloxacin—Flatulence—Niacin—atherosclerosis	0.000386	0.00189	CcSEcCtD
Sparfloxacin—Malaise—Simvastatin—atherosclerosis	0.000385	0.00188	CcSEcCtD
Sparfloxacin—Tension—Niacin—atherosclerosis	0.000385	0.00188	CcSEcCtD
Sparfloxacin—Discomfort—Lovastatin—atherosclerosis	0.000384	0.00188	CcSEcCtD
Sparfloxacin—Vertigo—Simvastatin—atherosclerosis	0.000384	0.00188	CcSEcCtD
Sparfloxacin—Chest pain—Ezetimibe—atherosclerosis	0.000381	0.00187	CcSEcCtD
Sparfloxacin—Myalgia—Ezetimibe—atherosclerosis	0.000381	0.00187	CcSEcCtD
Sparfloxacin—Arthralgia—Ezetimibe—atherosclerosis	0.000381	0.00187	CcSEcCtD
Sparfloxacin—Nervousness—Niacin—atherosclerosis	0.000381	0.00186	CcSEcCtD
Sparfloxacin—Flatulence—Pravastatin—atherosclerosis	0.00038	0.00186	CcSEcCtD
Sparfloxacin—Dry mouth—Lovastatin—atherosclerosis	0.00038	0.00186	CcSEcCtD
Sparfloxacin—Tension—Pravastatin—atherosclerosis	0.000379	0.00185	CcSEcCtD
Sparfloxacin—Dysgeusia—Pravastatin—atherosclerosis	0.000378	0.00185	CcSEcCtD
Sparfloxacin—Discomfort—Ezetimibe—atherosclerosis	0.000377	0.00184	CcSEcCtD
Sparfloxacin—Constipation—Rosuvastatin—atherosclerosis	0.000376	0.00184	CcSEcCtD
Sparfloxacin—Pain—Rosuvastatin—atherosclerosis	0.000376	0.00184	CcSEcCtD
Sparfloxacin—Confusional state—Lovastatin—atherosclerosis	0.000376	0.00184	CcSEcCtD
Sparfloxacin—Nervousness—Pravastatin—atherosclerosis	0.000375	0.00184	CcSEcCtD
Sparfloxacin—Dry mouth—Ezetimibe—atherosclerosis	0.000373	0.00182	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Lovastatin—atherosclerosis	0.000373	0.00182	CcSEcCtD
Sparfloxacin—Confusional state—Ezetimibe—atherosclerosis	0.000369	0.0018	CcSEcCtD
Sparfloxacin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—atherosclerosis	0.000367	0.0162	CbGpPWpGaD
Sparfloxacin—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000365	0.00179	CcSEcCtD
Sparfloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	0.000365	0.0162	CbGpPWpGaD
Sparfloxacin—Thrombocytopenia—Lovastatin—atherosclerosis	0.000365	0.00179	CcSEcCtD
Sparfloxacin—Chest pain—Simvastatin—atherosclerosis	0.000364	0.00178	CcSEcCtD
Sparfloxacin—Myalgia—Simvastatin—atherosclerosis	0.000364	0.00178	CcSEcCtD
Sparfloxacin—Arthralgia—Simvastatin—atherosclerosis	0.000364	0.00178	CcSEcCtD
Sparfloxacin—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000362	0.00177	CcSEcCtD
Sparfloxacin—Anxiety—Simvastatin—atherosclerosis	0.000362	0.00177	CcSEcCtD
Sparfloxacin—Tremor—Pravastatin—atherosclerosis	0.000362	0.00177	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00036	0.00176	CcSEcCtD
Sparfloxacin—Discomfort—Simvastatin—atherosclerosis	0.000359	0.00176	CcSEcCtD
Sparfloxacin—Angioedema—Niacin—atherosclerosis	0.000358	0.00175	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Pravastatin—atherosclerosis	0.000358	0.00175	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000358	0.00175	CcSEcCtD
Sparfloxacin—Anorexia—Lovastatin—atherosclerosis	0.000355	0.00174	CcSEcCtD
Sparfloxacin—Angioedema—Pravastatin—atherosclerosis	0.000353	0.00173	CcSEcCtD
Sparfloxacin—Vertigo—Niacin—atherosclerosis	0.000352	0.00172	CcSEcCtD
Sparfloxacin—Confusional state—Simvastatin—atherosclerosis	0.000351	0.00172	CcSEcCtD
Sparfloxacin—ABCB1—ABC-family proteins mediated transport—ABCG1—atherosclerosis	0.00035	0.0155	CbGpPWpGaD
Sparfloxacin—Urticaria—Rosuvastatin—atherosclerosis	0.000349	0.00171	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Simvastatin—atherosclerosis	0.000349	0.00171	CcSEcCtD
Sparfloxacin—Malaise—Pravastatin—atherosclerosis	0.000348	0.0017	CcSEcCtD
Sparfloxacin—Abdominal pain—Rosuvastatin—atherosclerosis	0.000348	0.0017	CcSEcCtD
Sparfloxacin—Vertigo—Pravastatin—atherosclerosis	0.000347	0.0017	CcSEcCtD
Sparfloxacin—Palpitations—Niacin—atherosclerosis	0.000347	0.0017	CcSEcCtD
Sparfloxacin—Cough—Niacin—atherosclerosis	0.000342	0.00167	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Simvastatin—atherosclerosis	0.000341	0.00167	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000339	0.00166	CcSEcCtD
Sparfloxacin—Insomnia—Lovastatin—atherosclerosis	0.000337	0.00165	CcSEcCtD
Sparfloxacin—Cough—Pravastatin—atherosclerosis	0.000337	0.00165	CcSEcCtD
Sparfloxacin—Paraesthesia—Lovastatin—atherosclerosis	0.000335	0.00164	CcSEcCtD
Sparfloxacin—Arthralgia—Niacin—atherosclerosis	0.000334	0.00163	CcSEcCtD
Sparfloxacin—Myalgia—Niacin—atherosclerosis	0.000334	0.00163	CcSEcCtD
Sparfloxacin—Hypertension—Pravastatin—atherosclerosis	0.000333	0.00163	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000333	0.00163	CcSEcCtD
Sparfloxacin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP7A1—atherosclerosis	0.000332	0.0147	CbGpPWpGaD
Sparfloxacin—Anorexia—Simvastatin—atherosclerosis	0.000332	0.00163	CcSEcCtD
Sparfloxacin—Dyspnoea—Lovastatin—atherosclerosis	0.000332	0.00163	CcSEcCtD
Sparfloxacin—Insomnia—Ezetimibe—atherosclerosis	0.000331	0.00162	CcSEcCtD
Sparfloxacin—Arthralgia—Pravastatin—atherosclerosis	0.000329	0.00161	CcSEcCtD
Sparfloxacin—Chest pain—Pravastatin—atherosclerosis	0.000329	0.00161	CcSEcCtD
Sparfloxacin—Myalgia—Pravastatin—atherosclerosis	0.000329	0.00161	CcSEcCtD
Sparfloxacin—Paraesthesia—Ezetimibe—atherosclerosis	0.000328	0.00161	CcSEcCtD
Sparfloxacin—Dyspepsia—Lovastatin—atherosclerosis	0.000328	0.00161	CcSEcCtD
Sparfloxacin—Anxiety—Pravastatin—atherosclerosis	0.000328	0.0016	CcSEcCtD
Sparfloxacin—Dry mouth—Niacin—atherosclerosis	0.000327	0.0016	CcSEcCtD
Sparfloxacin—Dyspnoea—Ezetimibe—atherosclerosis	0.000326	0.00159	CcSEcCtD
Sparfloxacin—Discomfort—Pravastatin—atherosclerosis	0.000325	0.00159	CcSEcCtD
Sparfloxacin—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000324	0.00159	CcSEcCtD
Sparfloxacin—Decreased appetite—Lovastatin—atherosclerosis	0.000324	0.00159	CcSEcCtD
Sparfloxacin—Dyspepsia—Ezetimibe—atherosclerosis	0.000322	0.00157	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Niacin—atherosclerosis	0.00032	0.00157	CcSEcCtD
Sparfloxacin—Constipation—Lovastatin—atherosclerosis	0.000319	0.00156	CcSEcCtD
Sparfloxacin—Pain—Lovastatin—atherosclerosis	0.000319	0.00156	CcSEcCtD
Sparfloxacin—Confusional state—Pravastatin—atherosclerosis	0.000318	0.00155	CcSEcCtD
Sparfloxacin—Decreased appetite—Ezetimibe—atherosclerosis	0.000318	0.00155	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000318	0.00155	CcSEcCtD
Sparfloxacin—Asthenia—Rosuvastatin—atherosclerosis	0.000315	0.00154	CcSEcCtD
Sparfloxacin—Insomnia—Simvastatin—atherosclerosis	0.000315	0.00154	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Pravastatin—atherosclerosis	0.000315	0.00154	CcSEcCtD
Sparfloxacin—Paraesthesia—Simvastatin—atherosclerosis	0.000313	0.00153	CcSEcCtD
Sparfloxacin—Pain—Ezetimibe—atherosclerosis	0.000313	0.00153	CcSEcCtD
Sparfloxacin—Constipation—Ezetimibe—atherosclerosis	0.000313	0.00153	CcSEcCtD
Sparfloxacin—Tachycardia—Niacin—atherosclerosis	0.000312	0.00153	CcSEcCtD
Sparfloxacin—Pruritus—Rosuvastatin—atherosclerosis	0.000311	0.00152	CcSEcCtD
Sparfloxacin—Dyspnoea—Simvastatin—atherosclerosis	0.000311	0.00152	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Niacin—atherosclerosis	0.000309	0.00151	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Pravastatin—atherosclerosis	0.000309	0.00151	CcSEcCtD
Sparfloxacin—Feeling abnormal—Lovastatin—atherosclerosis	0.000307	0.0015	CcSEcCtD
Sparfloxacin—Dyspepsia—Simvastatin—atherosclerosis	0.000307	0.0015	CcSEcCtD
Sparfloxacin—Anorexia—Niacin—atherosclerosis	0.000305	0.00149	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000305	0.00149	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Pravastatin—atherosclerosis	0.000305	0.00149	CcSEcCtD
Sparfloxacin—Decreased appetite—Simvastatin—atherosclerosis	0.000303	0.00148	CcSEcCtD
Sparfloxacin—Feeling abnormal—Ezetimibe—atherosclerosis	0.000301	0.00147	CcSEcCtD
Sparfloxacin—Diarrhoea—Rosuvastatin—atherosclerosis	0.000301	0.00147	CcSEcCtD
Sparfloxacin—Anorexia—Pravastatin—atherosclerosis	0.0003	0.00147	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000299	0.00146	CcSEcCtD
Sparfloxacin—Pain—Simvastatin—atherosclerosis	0.000298	0.00146	CcSEcCtD
Sparfloxacin—Constipation—Simvastatin—atherosclerosis	0.000298	0.00146	CcSEcCtD
Sparfloxacin—Urticaria—Lovastatin—atherosclerosis	0.000296	0.00145	CcSEcCtD
Sparfloxacin—Abdominal pain—Lovastatin—atherosclerosis	0.000295	0.00144	CcSEcCtD
Sparfloxacin—Body temperature increased—Lovastatin—atherosclerosis	0.000295	0.00144	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000292	0.00143	CcSEcCtD
Sparfloxacin—Dizziness—Rosuvastatin—atherosclerosis	0.000291	0.00142	CcSEcCtD
Sparfloxacin—Urticaria—Ezetimibe—atherosclerosis	0.00029	0.00142	CcSEcCtD
Sparfloxacin—Insomnia—Niacin—atherosclerosis	0.000289	0.00142	CcSEcCtD
Sparfloxacin—Body temperature increased—Ezetimibe—atherosclerosis	0.000289	0.00141	CcSEcCtD
Sparfloxacin—Abdominal pain—Ezetimibe—atherosclerosis	0.000289	0.00141	CcSEcCtD
Sparfloxacin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—atherosclerosis	0.000288	0.0127	CbGpPWpGaD
Sparfloxacin—Paraesthesia—Niacin—atherosclerosis	0.000287	0.00141	CcSEcCtD
Sparfloxacin—Feeling abnormal—Simvastatin—atherosclerosis	0.000287	0.00141	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000287	0.0014	CcSEcCtD
Sparfloxacin—Dyspnoea—Niacin—atherosclerosis	0.000285	0.0014	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000285	0.00139	CcSEcCtD
Sparfloxacin—Insomnia—Pravastatin—atherosclerosis	0.000285	0.00139	CcSEcCtD
Sparfloxacin—Somnolence—Niacin—atherosclerosis	0.000285	0.00139	CcSEcCtD
Sparfloxacin—Paraesthesia—Pravastatin—atherosclerosis	0.000283	0.00138	CcSEcCtD
Sparfloxacin—Dyspepsia—Niacin—atherosclerosis	0.000282	0.00138	CcSEcCtD
Sparfloxacin—Dyspnoea—Pravastatin—atherosclerosis	0.000281	0.00137	CcSEcCtD
Sparfloxacin—Decreased appetite—Niacin—atherosclerosis	0.000278	0.00136	CcSEcCtD
Sparfloxacin—Dyspepsia—Pravastatin—atherosclerosis	0.000277	0.00136	CcSEcCtD
Sparfloxacin—Rash—Rosuvastatin—atherosclerosis	0.000277	0.00136	CcSEcCtD
Sparfloxacin—Dermatitis—Rosuvastatin—atherosclerosis	0.000277	0.00136	CcSEcCtD
Sparfloxacin—Urticaria—Simvastatin—atherosclerosis	0.000277	0.00135	CcSEcCtD
Sparfloxacin—Body temperature increased—Simvastatin—atherosclerosis	0.000276	0.00135	CcSEcCtD
Sparfloxacin—Abdominal pain—Simvastatin—atherosclerosis	0.000276	0.00135	CcSEcCtD
Sparfloxacin—Headache—Rosuvastatin—atherosclerosis	0.000275	0.00135	CcSEcCtD
Sparfloxacin—ABCB1—ABC-family proteins mediated transport—ABCG5—atherosclerosis	0.000275	0.0122	CbGpPWpGaD
Sparfloxacin—Hypersensitivity—Lovastatin—atherosclerosis	0.000275	0.00134	CcSEcCtD
Sparfloxacin—Decreased appetite—Pravastatin—atherosclerosis	0.000274	0.00134	CcSEcCtD
Sparfloxacin—Pain—Niacin—atherosclerosis	0.000274	0.00134	CcSEcCtD
Sparfloxacin—Pain—Pravastatin—atherosclerosis	0.000269	0.00132	CcSEcCtD
Sparfloxacin—Constipation—Pravastatin—atherosclerosis	0.000269	0.00132	CcSEcCtD
Sparfloxacin—Hypersensitivity—Ezetimibe—atherosclerosis	0.000269	0.00132	CcSEcCtD
Sparfloxacin—Asthenia—Lovastatin—atherosclerosis	0.000267	0.00131	CcSEcCtD
Sparfloxacin—Pruritus—Lovastatin—atherosclerosis	0.000264	0.00129	CcSEcCtD
Sparfloxacin—Asthenia—Ezetimibe—atherosclerosis	0.000262	0.00128	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Niacin—atherosclerosis	0.000262	0.00128	CcSEcCtD
Sparfloxacin—Nausea—Rosuvastatin—atherosclerosis	0.000261	0.00128	CcSEcCtD
Sparfloxacin—Feeling abnormal—Pravastatin—atherosclerosis	0.00026	0.00127	CcSEcCtD
Sparfloxacin—Pruritus—Ezetimibe—atherosclerosis	0.000259	0.00127	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000258	0.00126	CcSEcCtD
Sparfloxacin—Hypersensitivity—Simvastatin—atherosclerosis	0.000257	0.00126	CcSEcCtD
Sparfloxacin—Diarrhoea—Lovastatin—atherosclerosis	0.000255	0.00125	CcSEcCtD
Sparfloxacin—Urticaria—Niacin—atherosclerosis	0.000254	0.00124	CcSEcCtD
Sparfloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.000253	0.0112	CbGpPWpGaD
Sparfloxacin—Abdominal pain—Niacin—atherosclerosis	0.000253	0.00124	CcSEcCtD
Sparfloxacin—Body temperature increased—Niacin—atherosclerosis	0.000253	0.00124	CcSEcCtD
Sparfloxacin—Urticaria—Pravastatin—atherosclerosis	0.00025	0.00123	CcSEcCtD
Sparfloxacin—Asthenia—Simvastatin—atherosclerosis	0.00025	0.00122	CcSEcCtD
Sparfloxacin—Diarrhoea—Ezetimibe—atherosclerosis	0.00025	0.00122	CcSEcCtD
Sparfloxacin—Body temperature increased—Pravastatin—atherosclerosis	0.000249	0.00122	CcSEcCtD
Sparfloxacin—Abdominal pain—Pravastatin—atherosclerosis	0.000249	0.00122	CcSEcCtD
Sparfloxacin—Pruritus—Simvastatin—atherosclerosis	0.000247	0.00121	CcSEcCtD
Sparfloxacin—Dizziness—Lovastatin—atherosclerosis	0.000246	0.00121	CcSEcCtD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CSF1R—atherosclerosis	0.000244	0.0108	CbGpPWpGaD
Sparfloxacin—Dizziness—Ezetimibe—atherosclerosis	0.000242	0.00118	CcSEcCtD
Sparfloxacin—Diarrhoea—Simvastatin—atherosclerosis	0.000238	0.00117	CcSEcCtD
Sparfloxacin—Vomiting—Lovastatin—atherosclerosis	0.000237	0.00116	CcSEcCtD
Sparfloxacin—Hypersensitivity—Niacin—atherosclerosis	0.000236	0.00115	CcSEcCtD
Sparfloxacin—Rash—Lovastatin—atherosclerosis	0.000235	0.00115	CcSEcCtD
Sparfloxacin—Dermatitis—Lovastatin—atherosclerosis	0.000235	0.00115	CcSEcCtD
Sparfloxacin—Headache—Lovastatin—atherosclerosis	0.000233	0.00114	CcSEcCtD
Sparfloxacin—Vomiting—Ezetimibe—atherosclerosis	0.000232	0.00114	CcSEcCtD
Sparfloxacin—Hypersensitivity—Pravastatin—atherosclerosis	0.000232	0.00114	CcSEcCtD
Sparfloxacin—Dizziness—Simvastatin—atherosclerosis	0.00023	0.00113	CcSEcCtD
Sparfloxacin—Rash—Ezetimibe—atherosclerosis	0.00023	0.00113	CcSEcCtD
Sparfloxacin—Dermatitis—Ezetimibe—atherosclerosis	0.00023	0.00113	CcSEcCtD
Sparfloxacin—Asthenia—Niacin—atherosclerosis	0.00023	0.00112	CcSEcCtD
Sparfloxacin—Headache—Ezetimibe—atherosclerosis	0.000229	0.00112	CcSEcCtD
Sparfloxacin—ABCC2—ABC-family proteins mediated transport—APOA1—atherosclerosis	0.000227	0.01	CbGpPWpGaD
Sparfloxacin—Pruritus—Niacin—atherosclerosis	0.000226	0.00111	CcSEcCtD
Sparfloxacin—Asthenia—Pravastatin—atherosclerosis	0.000226	0.00111	CcSEcCtD
Sparfloxacin—Pruritus—Pravastatin—atherosclerosis	0.000223	0.00109	CcSEcCtD
Sparfloxacin—Vomiting—Simvastatin—atherosclerosis	0.000222	0.00108	CcSEcCtD
Sparfloxacin—Nausea—Lovastatin—atherosclerosis	0.000221	0.00108	CcSEcCtD
Sparfloxacin—Rash—Simvastatin—atherosclerosis	0.00022	0.00108	CcSEcCtD
Sparfloxacin—Dermatitis—Simvastatin—atherosclerosis	0.00022	0.00107	CcSEcCtD
Sparfloxacin—Diarrhoea—Niacin—atherosclerosis	0.000219	0.00107	CcSEcCtD
Sparfloxacin—Headache—Simvastatin—atherosclerosis	0.000218	0.00107	CcSEcCtD
Sparfloxacin—Nausea—Ezetimibe—atherosclerosis	0.000217	0.00106	CcSEcCtD
Sparfloxacin—Diarrhoea—Pravastatin—atherosclerosis	0.000216	0.00106	CcSEcCtD
Sparfloxacin—Dizziness—Niacin—atherosclerosis	0.000212	0.00104	CcSEcCtD
Sparfloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.000209	0.00925	CbGpPWpGaD
Sparfloxacin—Dizziness—Pravastatin—atherosclerosis	0.000208	0.00102	CcSEcCtD
Sparfloxacin—Nausea—Simvastatin—atherosclerosis	0.000207	0.00101	CcSEcCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—UTS2—atherosclerosis	0.000204	0.00901	CbGpPWpGaD
Sparfloxacin—Vomiting—Niacin—atherosclerosis	0.000203	0.000996	CcSEcCtD
Sparfloxacin—Rash—Niacin—atherosclerosis	0.000202	0.000987	CcSEcCtD
Sparfloxacin—Dermatitis—Niacin—atherosclerosis	0.000202	0.000987	CcSEcCtD
Sparfloxacin—Headache—Niacin—atherosclerosis	0.0002	0.000981	CcSEcCtD
Sparfloxacin—Vomiting—Pravastatin—atherosclerosis	0.0002	0.00098	CcSEcCtD
Sparfloxacin—Rash—Pravastatin—atherosclerosis	0.000199	0.000972	CcSEcCtD
Sparfloxacin—Dermatitis—Pravastatin—atherosclerosis	0.000199	0.000971	CcSEcCtD
Sparfloxacin—Headache—Pravastatin—atherosclerosis	0.000197	0.000966	CcSEcCtD
Sparfloxacin—Nausea—Niacin—atherosclerosis	0.00019	0.00093	CcSEcCtD
Sparfloxacin—Nausea—Pravastatin—atherosclerosis	0.000187	0.000916	CcSEcCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—AHR—atherosclerosis	0.000186	0.00824	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	0.000179	0.00792	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—CST3—atherosclerosis	0.000172	0.0076	CbGpPWpGaD
Sparfloxacin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	0.000172	0.00759	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—NAMPT—atherosclerosis	0.000163	0.0072	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—F7—atherosclerosis	0.000154	0.00683	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.00014	0.00621	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—GHRL—atherosclerosis	0.000138	0.00609	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	0.000136	0.006	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000135	0.00596	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—ADIPOQ—atherosclerosis	0.000133	0.00589	CbGpPWpGaD
Sparfloxacin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.000119	0.00526	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	0.000109	0.00483	CbGpPWpGaD
Sparfloxacin—ABCB1—ABC-family proteins mediated transport—APOA1—atherosclerosis	0.000107	0.00472	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000106	0.00471	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—SIRT1—atherosclerosis	0.000105	0.00464	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—IL17A—atherosclerosis	0.000103	0.00455	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000103	0.00454	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ABCG8—atherosclerosis	9.85e-05	0.00436	CbGpPWpGaD
Sparfloxacin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	9.84e-05	0.00435	CbGpPWpGaD
Sparfloxacin—ABCC2—NRF2 pathway—HMOX1—atherosclerosis	9.76e-05	0.00432	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	9.74e-05	0.00431	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	9.65e-05	0.00427	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—PRKCG—atherosclerosis	9.6e-05	0.00425	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—CD40—atherosclerosis	9.12e-05	0.00403	CbGpPWpGaD
Sparfloxacin—ABCC2—NRF2 pathway—GSTM1—atherosclerosis	9.1e-05	0.00402	CbGpPWpGaD
Sparfloxacin—ABCC2—NRF2 pathway—AGER—atherosclerosis	8.77e-05	0.00388	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—PPARA—atherosclerosis	8.72e-05	0.00386	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—TRPV1—atherosclerosis	8.68e-05	0.00384	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—HMOX1—atherosclerosis	8.66e-05	0.00383	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ABCG5—atherosclerosis	8.35e-05	0.0037	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—AGTR1—atherosclerosis	8.34e-05	0.00369	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—LEP—atherosclerosis	8.28e-05	0.00366	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	8.23e-05	0.00364	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—EDN1—atherosclerosis	8.17e-05	0.00361	CbGpPWpGaD
Sparfloxacin—ABCC2—NRF2 pathway—PDGFB—atherosclerosis	7.83e-05	0.00346	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ABCG1—atherosclerosis	7.78e-05	0.00344	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—NOS2—atherosclerosis	7.71e-05	0.00341	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—PPARG—atherosclerosis	7.21e-05	0.00319	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	7.12e-05	0.00315	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	7.06e-05	0.00312	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—IL10—atherosclerosis	6.99e-05	0.00309	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—CD40LG—atherosclerosis	6.99e-05	0.00309	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—LEP—atherosclerosis	6.64e-05	0.00294	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—FASLG—atherosclerosis	6.5e-05	0.00288	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—SERPINE1—atherosclerosis	6.49e-05	0.00287	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—TRPV1—atherosclerosis	6.35e-05	0.00281	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—NOS2—atherosclerosis	6.19e-05	0.00274	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—CETP—atherosclerosis	6.18e-05	0.00274	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ABCG5—atherosclerosis	6.11e-05	0.0027	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	5.91e-05	0.00261	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	5.9e-05	0.00261	CbGpPWpGaD
Sparfloxacin—Gatifloxacin—ALB—atherosclerosis	5.71e-05	1	CrCbGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—PLAT—atherosclerosis	5.45e-05	0.00241	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—atherosclerosis	5.21e-05	0.00231	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	5.13e-05	0.00227	CbGpPWpGaD
Sparfloxacin—SLC22A5—SLC-mediated transmembrane transport—ALB—atherosclerosis	5.05e-05	0.00224	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	5.04e-05	0.00223	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—MAPK8—atherosclerosis	4.84e-05	0.00214	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ABCG4—atherosclerosis	4.83e-05	0.00214	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	4.65e-05	0.00206	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—PLG—atherosclerosis	4.63e-05	0.00205	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ABCG8—atherosclerosis	4.63e-05	0.00205	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—CETP—atherosclerosis	4.52e-05	0.002	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	4.47e-05	0.00198	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	4.4e-05	0.00195	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—HMOX1—atherosclerosis	4.28e-05	0.00189	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	4.27e-05	0.00189	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—IFNG—atherosclerosis	4.11e-05	0.00182	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—APOB—atherosclerosis	4.1e-05	0.00181	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	3.99e-05	0.00176	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—PLAT—atherosclerosis	3.98e-05	0.00176	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—CXCL8—atherosclerosis	3.82e-05	0.00169	CbGpPWpGaD
Sparfloxacin—ABCC2—NRF2 pathway—TGFB1—atherosclerosis	3.71e-05	0.00164	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—IL1B—atherosclerosis	3.67e-05	0.00162	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ABCG1—atherosclerosis	3.66e-05	0.00162	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	3.6e-05	0.00159	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—atherosclerosis	3.59e-05	0.00159	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—PPARA—atherosclerosis	3.46e-05	0.00153	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—PLG—atherosclerosis	3.39e-05	0.0015	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	3.32e-05	0.00147	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.24e-05	0.00143	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	3.21e-05	0.00142	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	3.13e-05	0.00138	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—VEGFA—atherosclerosis	3.1e-05	0.00137	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—IL6—atherosclerosis	3.09e-05	0.00137	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—APOB—atherosclerosis	3e-05	0.00132	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	2.98e-05	0.00132	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	2.97e-05	0.00131	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	2.87e-05	0.00127	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—TGFB1—atherosclerosis	2.85e-05	0.00126	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	2.71e-05	0.0012	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—TNF—atherosclerosis	2.66e-05	0.00118	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—LDLRAP1—atherosclerosis	2.66e-05	0.00118	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ALB—atherosclerosis	2.57e-05	0.00114	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.53e-05	0.00112	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PLTP—atherosclerosis	2.5e-05	0.00111	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.37e-05	0.00105	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	2.35e-05	0.00104	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	2.29e-05	0.00101	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—LTA4H—atherosclerosis	2.17e-05	0.000959	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ABCG8—atherosclerosis	2.17e-05	0.000959	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—atherosclerosis	2.13e-05	0.000943	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—CETP—atherosclerosis	2.13e-05	0.00094	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	1.95e-05	0.00086	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—MAPK3—atherosclerosis	1.91e-05	0.000843	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ALB—atherosclerosis	1.88e-05	0.00083	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	1.87e-05	0.000829	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ABCG1—atherosclerosis	1.71e-05	0.000758	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	1.69e-05	0.000747	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	1.66e-05	0.000734	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—LCAT—atherosclerosis	1.61e-05	0.000713	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—FABP4—atherosclerosis	1.61e-05	0.000713	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	1.59e-05	0.000705	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—APOA4—atherosclerosis	1.58e-05	0.0007	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP7A1—atherosclerosis	1.55e-05	0.000687	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	1.53e-05	0.000678	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	1.47e-05	0.00065	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	1.45e-05	0.000641	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP27A1—atherosclerosis	1.44e-05	0.000635	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	1.41e-05	0.000623	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	1.41e-05	0.000622	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PLA2G2A—atherosclerosis	1.36e-05	0.000602	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—APOA2—atherosclerosis	1.36e-05	0.000602	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ALOX5AP—atherosclerosis	1.36e-05	0.000602	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ALOX15—atherosclerosis	1.36e-05	0.000602	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ABCG5—atherosclerosis	1.35e-05	0.000595	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.31e-05	0.000581	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—LPA—atherosclerosis	1.3e-05	0.000575	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—BGN—atherosclerosis	1.26e-05	0.000557	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—APOA5—atherosclerosis	1.25e-05	0.000551	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PLA2G1B—atherosclerosis	1.2e-05	0.00053	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.19e-05	0.000525	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ALOX5—atherosclerosis	1.16e-05	0.000512	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.11e-05	0.000493	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NAMPT—atherosclerosis	1.04e-05	0.000459	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—LIPC—atherosclerosis	1.03e-05	0.000456	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—APOC3—atherosclerosis	1.03e-05	0.000454	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—LDLR—atherosclerosis	1.02e-05	0.000451	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CETP—atherosclerosis	9.96e-06	0.00044	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	9.78e-06	0.000432	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SCARB1—atherosclerosis	9.54e-06	0.000422	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HMGCR—atherosclerosis	9e-06	0.000398	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	8.83e-06	0.00039	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ABCA1—atherosclerosis	8.03e-06	0.000355	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HMOX1—atherosclerosis	6.89e-06	0.000305	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—APOB—atherosclerosis	6.6e-06	0.000292	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTM1—atherosclerosis	6.42e-06	0.000284	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—LPL—atherosclerosis	6.3e-06	0.000279	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GPX1—atherosclerosis	6.14e-06	0.000272	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CD36—atherosclerosis	5.98e-06	0.000265	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—MTHFR—atherosclerosis	5.67e-06	0.000251	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PPARA—atherosclerosis	5.56e-06	0.000246	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—AGT—atherosclerosis	5.39e-06	0.000238	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—APOE—atherosclerosis	5.28e-06	0.000234	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CAV1—atherosclerosis	5.23e-06	0.000231	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—APOA1—atherosclerosis	5.22e-06	0.000231	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3CG—atherosclerosis	4.76e-06	0.000211	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PPARG—atherosclerosis	4.6e-06	0.000203	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—INS—atherosclerosis	4.51e-06	0.000199	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ALB—atherosclerosis	4.13e-06	0.000183	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NOS3—atherosclerosis	3.95e-06	0.000175	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PTGS2—atherosclerosis	3.62e-06	0.00016	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—AKT1—atherosclerosis	1.82e-06	8.04e-05	CbGpPWpGaD
